EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcutaneous Auricular Vagus Nerve Stimulation Restores Cognitive Impairment in Morphine‐Withdrawn Rats: Role of BDNF and Glial Cells in the Hippocampus

Somayeh Nazari, Saba Niknamfar, Hamed Ghazvini, Raheleh Rafaiee, Armin Allahverdy, Habibolah Khazaie, Seyedeh Masoumeh Seyedhosseini Tamijani iD

Addiction Biology · 2025-04 · 30 (4)

DOI: 10.1111/adb.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction Biology, online erschienen am 04.04.2025. Verfasst von Somayeh Nazari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Hippocampus, Cognitive Dysfunction, Vagus Nerve Stimulation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mazandaran University of Medical Sciences, Iran National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opioid use disorder (OUD) is a significant mental health problem, with prolonged usage potentially resulting in tolerance, addiction and cognitive decline, including learning and memory deficiency. At present, pharmacotherapy serves as the primary treatment approach for OUD. However, despite its status as a cornerstone of treatment, pharmacotherapy has certain limitations, thereby mandating the exploration of alternative modalities. This study evaluated the efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) in multiple cognitive domains in morphine‐withdrawn rats. To induce morphine dependence, the rats were administered 10 mg/kg morphine for 10 consecutive days. taVNS was administered to the left ear of each rat and continued for 2 weeks. After electrical stimulation, various cognitive and emotional functions were assessed through related behavioural tasks, including open field, Y‐maze, novel object recognition and elevated plus maze tests. GFAP, Iba1 and BDNF expression levels in the hippocampus were determined via quantitative polymerase chain reaction (qPCR). Our investigation revealed that taVNS ameliorated the impairment of working and recognition memory induced by morphine in behavioural tests. Additionally, it exerts an anxiolytic effect. Moreover, taVNS counteracted the decreased concentration of brain‐derived neurotrophic factor (BDNF) and elevated levels of glial fibrillary acidic protein (GFAP) caused by morphine. Nonetheless, taVNS applied only at a frequency of 100 Hz has the potential to lower Iba1 levels independently of prior exposure to morphine. taVNS has been shown to exert a neuroprotective effect on morphine‐withdrawn rats. This outcome indicates that taVNS can be employed as a supplementary therapy with other pharmacological interventions for OUD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain-Derived Neurotrophic FactorHippocampusCognitive DysfunctionVagus Nerve StimulationNeurogliaSubstance Withdrawal SyndromeTranscutaneous Electric Nerve StimulationMorphine DependenceAnimalsRatsMaleMorphine

Stichwörter der Autor:innen

BDNFcognitive impairmentmorphineneuroinflammationvagus nerve stimulation

Substanzen

Brain-Derived Neurotrophic FactorMorphineBdnf protein, rat

Autor:innen und Institutionen

  • Student Research Committee, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Neurodevelopmental Disorders Prevention Center, Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Psychiatry, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.

ORCID-Profile: Seyedeh Masoumeh Seyedhosseini Tamijani

Förderung

  • Mazandaran University of Medical Sciences
  • Iran National Science Foundation

Zitieren

APA

Nazari, S., Niknamfar, S., Ghazvini, H., Rafaiee, R., Allahverdy, A., Khazaie, H., & Tamijani, S. M. S. (2025). Transcutaneous Auricular Vagus Nerve Stimulation Restores Cognitive Impairment in Morphine‐Withdrawn Rats: Role of BDNF and Glial Cells in the Hippocampus. Addiction Biology, 30(4). https://doi.org/10.1111/adb.70016

Vancouver

Nazari S, Niknamfar S, Ghazvini H, Rafaiee R, Allahverdy A, Khazaie H, et al. Transcutaneous Auricular Vagus Nerve Stimulation Restores Cognitive Impairment in Morphine‐Withdrawn Rats: Role of BDNF and Glial Cells in the Hippocampus. Addiction Biology. 2025;30(4). doi:10.1111/adb.70016

BibTeX
@article{Nazari2025,
  author = {Nazari, Somayeh and Niknamfar, Saba and Ghazvini, Hamed and Rafaiee, Raheleh and Allahverdy, Armin and Khazaie, Habibolah and Tamijani, Seyedeh Masoumeh Seyedhosseini},
  title = {Transcutaneous Auricular Vagus Nerve Stimulation Restores Cognitive Impairment in Morphine‐Withdrawn Rats: Role of BDNF and Glial Cells in the Hippocampus},
  journal = {Addiction Biology},
  year = {2025},
  volume = {30},
  number = {4},
  doi = {10.1111/adb.70016}
}
Kostenlos starten →